Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma

Lisha Wang, Sean R. Williamson, Shaobo Zhang, Jiaoti Huang, Rodolfo Montironi, Darrell D. Davison, Mingsheng Wang, Jorge L. Yao, Antonio Lopez-Beltran, Adeboye O. Osunkoya, Gregory T. Maclennan, Lee Ann Baldridge, Xiang Du, Liang Cheng

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Small cell carcinoma of the prostate (PSCC) is a highly aggressive malignancy that often develops in patients previously treated with hormonal therapy for metastatic prostatic acinar adenocarcinoma. The TMPRSS2-ERG gene rearrangement is highly specific for prostate cancer and shared by PSCC; however, the role of androgen receptor (AR) gene alterations and interaction with TMPRSS2-ERG rearrangement are incompletely understood in PSCC. Sixty-one cases of PSCC were examined for AR gene copy number and TMPRSS2-ERG rearrangement by fluorescence in situ hybridization (FISH) and AR protein expression by immunohistochemistry. Of 61 cases of PSCC, 51% (31/61) demonstrated increased AR gene copy number (FISH+), 54% (33/61) were positive for TMPRSS2-ERG gene fusion, and 38% (23/61) showed AR protein expression. Of the 31 AR FISH+ cases, 23 also showed TMPRSS2-ERG gene fusion, and 16 expressed AR protein. Of the 33 cases with TMPRSS2-ERG fusion, 28 were AR FISH+ or expressed AR protein. Statistically significant correlations were observed between AR gene copy number or AR protein expression and TMPRSS2-ERG gene fusion (P=0.001 and P=0.03, respectively). In summary, high AR gene copy number emerges during the development of PSCC, often in association with TMPRSS2-ERG rearrangement. This potential mechanism warrants further study. Improvement will come from understanding the biology of the disease and integrating new therapies into the treatment of this rare and aggressive tumor.

Original languageEnglish
Pages (from-to)900-907
Number of pages8
JournalMolecular Carcinogenesis
Volume54
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Small Cell Carcinoma
Gene Dosage
Androgen Receptors
Fluorescence In Situ Hybridization
Gene Fusion
Proteins
Gene Rearrangement
Prostate
Neoplasms
Prostatic Neoplasms
Adenocarcinoma
Therapeutics
Immunohistochemistry

Keywords

  • Androgen receptor
  • Gene copy number
  • Molecular cytogenetics, fluorescence in situ hybridization
  • Prostate
  • Small cell carcinoma
  • TMPRSS2-ERG rearrangement
  • Tumorigenesis

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma. / Wang, Lisha; Williamson, Sean R.; Zhang, Shaobo; Huang, Jiaoti; Montironi, Rodolfo; Davison, Darrell D.; Wang, Mingsheng; Yao, Jorge L.; Lopez-Beltran, Antonio; Osunkoya, Adeboye O.; Maclennan, Gregory T.; Baldridge, Lee Ann; Du, Xiang; Cheng, Liang.

In: Molecular Carcinogenesis, Vol. 54, No. 9, 01.09.2015, p. 900-907.

Research output: Contribution to journalArticle

Wang, L, Williamson, SR, Zhang, S, Huang, J, Montironi, R, Davison, DD, Wang, M, Yao, JL, Lopez-Beltran, A, Osunkoya, AO, Maclennan, GT, Baldridge, LA, Du, X & Cheng, L 2015, 'Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma', Molecular Carcinogenesis, vol. 54, no. 9, pp. 900-907. https://doi.org/10.1002/mc.22162
Wang, Lisha ; Williamson, Sean R. ; Zhang, Shaobo ; Huang, Jiaoti ; Montironi, Rodolfo ; Davison, Darrell D. ; Wang, Mingsheng ; Yao, Jorge L. ; Lopez-Beltran, Antonio ; Osunkoya, Adeboye O. ; Maclennan, Gregory T. ; Baldridge, Lee Ann ; Du, Xiang ; Cheng, Liang. / Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma. In: Molecular Carcinogenesis. 2015 ; Vol. 54, No. 9. pp. 900-907.
@article{51908f7fbd8c4e558bd2b3d401960f16,
title = "Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma",
abstract = "Small cell carcinoma of the prostate (PSCC) is a highly aggressive malignancy that often develops in patients previously treated with hormonal therapy for metastatic prostatic acinar adenocarcinoma. The TMPRSS2-ERG gene rearrangement is highly specific for prostate cancer and shared by PSCC; however, the role of androgen receptor (AR) gene alterations and interaction with TMPRSS2-ERG rearrangement are incompletely understood in PSCC. Sixty-one cases of PSCC were examined for AR gene copy number and TMPRSS2-ERG rearrangement by fluorescence in situ hybridization (FISH) and AR protein expression by immunohistochemistry. Of 61 cases of PSCC, 51{\%} (31/61) demonstrated increased AR gene copy number (FISH+), 54{\%} (33/61) were positive for TMPRSS2-ERG gene fusion, and 38{\%} (23/61) showed AR protein expression. Of the 31 AR FISH+ cases, 23 also showed TMPRSS2-ERG gene fusion, and 16 expressed AR protein. Of the 33 cases with TMPRSS2-ERG fusion, 28 were AR FISH+ or expressed AR protein. Statistically significant correlations were observed between AR gene copy number or AR protein expression and TMPRSS2-ERG gene fusion (P=0.001 and P=0.03, respectively). In summary, high AR gene copy number emerges during the development of PSCC, often in association with TMPRSS2-ERG rearrangement. This potential mechanism warrants further study. Improvement will come from understanding the biology of the disease and integrating new therapies into the treatment of this rare and aggressive tumor.",
keywords = "Androgen receptor, Gene copy number, Molecular cytogenetics, fluorescence in situ hybridization, Prostate, Small cell carcinoma, TMPRSS2-ERG rearrangement, Tumorigenesis",
author = "Lisha Wang and Williamson, {Sean R.} and Shaobo Zhang and Jiaoti Huang and Rodolfo Montironi and Davison, {Darrell D.} and Mingsheng Wang and Yao, {Jorge L.} and Antonio Lopez-Beltran and Osunkoya, {Adeboye O.} and Maclennan, {Gregory T.} and Baldridge, {Lee Ann} and Xiang Du and Liang Cheng",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/mc.22162",
language = "English",
volume = "54",
pages = "900--907",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma

AU - Wang, Lisha

AU - Williamson, Sean R.

AU - Zhang, Shaobo

AU - Huang, Jiaoti

AU - Montironi, Rodolfo

AU - Davison, Darrell D.

AU - Wang, Mingsheng

AU - Yao, Jorge L.

AU - Lopez-Beltran, Antonio

AU - Osunkoya, Adeboye O.

AU - Maclennan, Gregory T.

AU - Baldridge, Lee Ann

AU - Du, Xiang

AU - Cheng, Liang

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Small cell carcinoma of the prostate (PSCC) is a highly aggressive malignancy that often develops in patients previously treated with hormonal therapy for metastatic prostatic acinar adenocarcinoma. The TMPRSS2-ERG gene rearrangement is highly specific for prostate cancer and shared by PSCC; however, the role of androgen receptor (AR) gene alterations and interaction with TMPRSS2-ERG rearrangement are incompletely understood in PSCC. Sixty-one cases of PSCC were examined for AR gene copy number and TMPRSS2-ERG rearrangement by fluorescence in situ hybridization (FISH) and AR protein expression by immunohistochemistry. Of 61 cases of PSCC, 51% (31/61) demonstrated increased AR gene copy number (FISH+), 54% (33/61) were positive for TMPRSS2-ERG gene fusion, and 38% (23/61) showed AR protein expression. Of the 31 AR FISH+ cases, 23 also showed TMPRSS2-ERG gene fusion, and 16 expressed AR protein. Of the 33 cases with TMPRSS2-ERG fusion, 28 were AR FISH+ or expressed AR protein. Statistically significant correlations were observed between AR gene copy number or AR protein expression and TMPRSS2-ERG gene fusion (P=0.001 and P=0.03, respectively). In summary, high AR gene copy number emerges during the development of PSCC, often in association with TMPRSS2-ERG rearrangement. This potential mechanism warrants further study. Improvement will come from understanding the biology of the disease and integrating new therapies into the treatment of this rare and aggressive tumor.

AB - Small cell carcinoma of the prostate (PSCC) is a highly aggressive malignancy that often develops in patients previously treated with hormonal therapy for metastatic prostatic acinar adenocarcinoma. The TMPRSS2-ERG gene rearrangement is highly specific for prostate cancer and shared by PSCC; however, the role of androgen receptor (AR) gene alterations and interaction with TMPRSS2-ERG rearrangement are incompletely understood in PSCC. Sixty-one cases of PSCC were examined for AR gene copy number and TMPRSS2-ERG rearrangement by fluorescence in situ hybridization (FISH) and AR protein expression by immunohistochemistry. Of 61 cases of PSCC, 51% (31/61) demonstrated increased AR gene copy number (FISH+), 54% (33/61) were positive for TMPRSS2-ERG gene fusion, and 38% (23/61) showed AR protein expression. Of the 31 AR FISH+ cases, 23 also showed TMPRSS2-ERG gene fusion, and 16 expressed AR protein. Of the 33 cases with TMPRSS2-ERG fusion, 28 were AR FISH+ or expressed AR protein. Statistically significant correlations were observed between AR gene copy number or AR protein expression and TMPRSS2-ERG gene fusion (P=0.001 and P=0.03, respectively). In summary, high AR gene copy number emerges during the development of PSCC, often in association with TMPRSS2-ERG rearrangement. This potential mechanism warrants further study. Improvement will come from understanding the biology of the disease and integrating new therapies into the treatment of this rare and aggressive tumor.

KW - Androgen receptor

KW - Gene copy number

KW - Molecular cytogenetics, fluorescence in situ hybridization

KW - Prostate

KW - Small cell carcinoma

KW - TMPRSS2-ERG rearrangement

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84938928755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938928755&partnerID=8YFLogxK

U2 - 10.1002/mc.22162

DO - 10.1002/mc.22162

M3 - Article

C2 - 24777847

AN - SCOPUS:84938928755

VL - 54

SP - 900

EP - 907

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 9

ER -